SS
BOLD

SBI Securities’s Boundless Bio BOLD Stock Holding History

SBI Securities’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5 Buy
2
+1
+100% +$2 ﹤0.01% 3996
2026
Q1 		$1 Buy
+1
New +$1 ﹤0.01% 4002

Other funds holding BOLD

AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

SBI Securities's BOLD Position: Q2 2026 in Review

SBI Securities increased its Boundless Bio (BOLD) stake by 100% in Q2 2026, buying an estimated $2 and bringing the position to 2 shares worth $5. The position accounts for ﹤0.01% of the portfolio, ranked #3996.

SBI Securities first reported a position in BOLD in Q1 2026 and has held it in 2 quarters since. 40 funds tracked by Wall St. Rank hold BOLD as of Q2 2026.

  • SBI Securities held 2 shares of Boundless Bio worth $5 as of Q2 2026.
  • SBI Securities bought 1 Boundless Bio share in Q2 2026, an estimated $2.
  • Boundless Bio made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3996 holding.
  • SBI Securities first reported a position in Boundless Bio in Q1 2026 and has held it in 2 quarters since.
  • 40 funds tracked by Wall St. Rank held Boundless Bio as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.